BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7693333)

  • 1. Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media.
    Pratt SE; Pollak MN
    Cancer Res; 1993 Nov; 53(21):5193-8. PubMed ID: 7693333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for insulin-like growth factor binding protein 5 in the antiproliferative action of the antiestrogen ICI 182780.
    Huynh H; Yang XF; Pollak M
    Cell Growth Differ; 1996 Nov; 7(11):1501-6. PubMed ID: 8930399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of insulin-like growth factor binding protein expression by ICI 182,780 in a tamoxifen-resistant human breast cancer cell line.
    Parisot JP; Leeding KS; Hu XF; DeLuise M; Zalcberg JR; Bach LA
    Breast Cancer Res Treat; 1999 Jun; 55(3):231-42. PubMed ID: 10517168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor binding protein-3 induces apoptosis in MCF7 breast cancer cells.
    Nickerson T; Huynh H; Pollak M
    Biochem Biophys Res Commun; 1997 Aug; 237(3):690-3. PubMed ID: 9299428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    BrĂ¼nner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
    Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
    Chan TW; Pollak M; Huynh H
    Clin Cancer Res; 2001 Aug; 7(8):2545-54. PubMed ID: 11489838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells.
    Sheikh MS; Shao ZM; Hussain A; Clemmons DR; Chen JC; Roberts CT; LeRoith D; Fontana JA
    J Cell Physiol; 1993 Jun; 155(3):556-67. PubMed ID: 7684042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor binding protein 3 (IGF-BP3) inhibits estrogen-stimulated breast cancer cell proliferation.
    Pratt SE; Pollak MN
    Biochem Biophys Res Commun; 1994 Jan; 198(1):292-7. PubMed ID: 7507320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator.
    Juncker-Jensen A; Lykkesfeldt AE; Worm J; Ralfkiaer U; Espelund U; Jepsen JS
    Growth Horm IGF Res; 2006 Aug; 16(4):224-39. PubMed ID: 16893667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-associated insulin-like growth factor-binding proteins inhibit insulin-like growth factor-I-induced endometrial cancer cell proliferation.
    Bermont L; Fauconnet S; Lamielle F; Adessi GL
    Cell Mol Biol (Noisy-le-grand); 2000 Nov; 46(7):1173-82. PubMed ID: 11075947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of insulin-like growth factors and their binding proteins in the estrogen responsive Ishikawa human endometrial cancer cell line.
    Hana V; Murphy LJ
    Endocrinology; 1994 Dec; 135(6):2511-6. PubMed ID: 7527333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line.
    Chen JC; Shao ZM; Sheikh MS; Hussain A; LeRoith D; Roberts CT; Fontana JA
    J Cell Physiol; 1994 Jan; 158(1):69-78. PubMed ID: 7505280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of endometrial cancer cell growth by tamoxifen is associated with increased insulin-like growth factor (IGF)-I induced tyrosine phosphorylation and reduction in IGF binding proteins.
    Kleinman D; Karas M; Danilenko M; Arbell A; Roberts CT; LeRoith D; Levy J; Sharoni Y
    Endocrinology; 1996 Mar; 137(3):1089-95. PubMed ID: 8603578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of insulin-like growth factor binding proteins by T-47D human breast cancer cells: regulation by progestins and antiestrogens.
    Coutts A; Murphy LJ; Murphy LC
    Breast Cancer Res Treat; 1994; 32(2):153-64. PubMed ID: 7532465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and hormonal regulation of radioimmunoassayable IGF-I (insulin-like growth factor I) like activity and IGF-binding proteins secreted by human breast cancer cells.
    Ahmed SR; Manni A; Gray G; Hammond JM
    Anticancer Res; 1990; 10(5A):1217-23. PubMed ID: 1700662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells.
    Vignon F; Lippman ME; Nawata H; Derocq D; Rochefort H
    Cancer Res; 1984 May; 44(5):2084-8. PubMed ID: 6713400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol.
    Martin JL; Coverley JA; Pattison ST; Baxter RC
    Endocrinology; 1995 Mar; 136(3):1219-26. PubMed ID: 7532580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation.
    Zhou-Li F; Albaladejo V; Joly-Pharaboz MO; Nicolas B; Andre J
    Endocrinology; 1992 Mar; 130(3):1145-52. PubMed ID: 1537281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretion and biological actions of insulin-like growth factor binding proteins in two human tumor-derived cell lines in vitro.
    Camacho-Hubner C; McCusker RH; Clemmons DR
    J Cell Physiol; 1991 Aug; 148(2):281-9. PubMed ID: 1715344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human osteoblasts' proliferative responses to strain and 17beta-estradiol are mediated by the estrogen receptor and the receptor for insulin-like growth factor I.
    Cheng MZ; Rawlinson SC; Pitsillides AA; Zaman G; Mohan S; Baylink DJ; Lanyon LE
    J Bone Miner Res; 2002 Apr; 17(4):593-602. PubMed ID: 11924572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.